Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $7.85 in the prior trading day, 89bio Inc (NASDAQ: ETNB) closed at $7.15, down -8.92%. In other words, the price has decreased by -$8.92 from its previous closing price. On the day, 1.67 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ETNB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.19 and its Current Ratio is at 13.19. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on January 12, 2024, whereas the target price for the stock was revised from $24 to $15.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 30 ’25 when RA CAPITAL MANAGEMENT, L.P. bought 5,714,285 shares for $8.75 per share. The transaction valued at 49,999,994 led to the insider holds 19,554,319 shares of the business.
McWherter Charles bought 10,000 shares of ETNB for $67,100 on Jan 22 ’25. The Director now owns 25,000 shares after completing the transaction at $6.71 per share. On Jan 21 ’25, another insider, McWherter Charles, who serves as the Director of the company, bought 5,000 shares for $6.55 each. As a result, the insider paid 32,750 and bolstered with 15,000 shares of the company.
Stock Price History:
Over the past 52 weeks, ETNB has reached a high of $13.71, while it has fallen to a 52-week low of $5.99. The 50-Day Moving Average of the stock is -18.52%, while the 200-Day Moving Average is calculated to be -15.32%.
Shares Statistics:
A total of 145.98M shares are outstanding, with a floating share count of 138.97M. Insiders hold about 4.80% of the company’s shares, while institutions hold 89.85% stake in the company.